If and the biological pacemaker

Pharmacological Research

Volumn 53, Issue 5, 2006, Pages 407-415

  Robinson, Richard B ^a   Brink, Peter R ^b   Cohen, Ira S ^a,b   Rosen, Michael R ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Automaticity; Biological pacemaker; Gene therapy; HCN; Stem cells

Indexed keywords

ACETYLCHOLINE; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CALCIUM; CARBACHOL; CATECHOLAMINE; CYCLIC AMP; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED ION CHANNEL 2; ION CHANNEL; ISOPRENALINE; POTASSIUM; UNCLASSIFIED DRUG;

ARTIFICIAL HEART PACEMAKER; AUTONOMIC NERVOUS SYSTEM; CELL BASED GENE THERAPY; CELL TRANSPLANTATION; DRUG MECHANISM; GENE; GENE THERAPY; HEART RATE; HEART RHYTHM; HUMAN; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED ION CHANNEL GENE; ION CURRENT; MULTIGENE FAMILY; NONHUMAN; PACEMAKER; PACEMAKER NERVE CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REVIEW; SINUS NODE; STEM CELL TRANSPLANTATION;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CELL TRANSPLANTATION; GENE THERAPY; HEART; HEART DISEASES; HEART RATE; HUMANS; ION CHANNELS; PROTEIN ISOFORMS; SINOATRIAL NODE;

EID: 33646580107     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.03.007     Document Type: Review

References (58)

1. Edelberg J.M., Aird W.C., and Rosenberg R.D. Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J Clin Invest 101 2 (1998) 337-343
2. Edelberg J.M., Huang D.T., Josephson M.E., and Rosenberg R.D. Molecular enhancement of porcine cardiac chronotropy. Heart 86 5 (2001) 559-562
3. Miake J., Marban E., and Nuss H.B. Gene therapy: biological pacemaker created by gene transfer. Nature 419 6903 (2002) 132-133
4. Qu J., Plotnikov A.N., Danilo P.J., Shlapakova I., Cohen I.S., Robinson R.B., et al. Expression and function of a biological pacemaker in canine heart. Circulation 107 8 (2003) 1106-1109
5. Plotnikov A.N., Sosunov E.A., Qu J., Shlapakova I.N., Anyukhovsky E.P., Liu L., et al. Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation 109 (2004) 506-512
6. Potapova I., Plotnikov A., Lu Z., Danilo Jr. P., Valiunas V., Qu J., et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res 94 (2004) 952-959
7. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22 10 (2004) 1282-1289
8. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marban E., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111 1 (2005) 11-20
9. Lin G., Cai J., Jiang H., Shen H., Jiang X., Yu Q., et al. Biological pacemaker created by fetal cardiomyocyte transplantation. J Biomed Sci 12 3 (2005) 513-519
10. Rosen M.R., Brink P.R., Cohen I.S., and Robinson R.B. Genes, stem cells and biological pacemakers. Cardiovasc Res 64 (2004) 12-23
11. f) current: autonomic regulation and the control of pacing. In: Morad M., Ebashi S., Trautwein W., and Kurachi Y. (Eds). Molecular physiology and pharmacology of cardiac ion channels and transporters (1996), Kluwer Academic Publishers, Dordrecht 31-37
12. Cohen I.S., and Robinson R.B. Pacemaker current and automatic rhythms: toward a molecular understanding. In: Clancy C.E., and Kass R.S. (Eds). Basis and Treatment of Cardiac Arrhythmias (2006), Springer Verlag, Berlin 41-72
13. Biel M., Schneider A., and Wahl C. Cardiac HCN channels. Structure, function, and modulation. Trends Cardiovasc Med 12 5 (2002) 206-212
14. Baruscotti M., and DiFrancesco D. Pacemaker channels. Ann NY Acad Sci 1015 (2004) 111-121
15. DiFrancesco D., and Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 351 (1991) 145-147
16. Irisawa H., Brown H.F., and Giles W. Cardiac pacemaking in the sino-atrial node. Physiol Rev 73 (1993) 197-227
17. Boyett M.R., Honjo H., and Kodama I. The sino-atrial node, a heterogeneous pacemaker structure. Cardiovasc Res 47 4 (2000) 658-687
18. DiFrancesco D., Ducouret P., and Robinson R.B. Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science 243 (1989) 669-671
19. 2+ and hyperpolarization-activated currents to autonomic agonists in the rabbit sino-atrial node. J Physiol (Lond) 491 (1996) 347-355
20. Ludwig A., Zong X., Jeglitsch M., Hofmann F., and Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature 393 (1998) 587-591
21. Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R., Siegelbaum S.A., et al. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 93 (1998) 1-20
22. Robinson R.B., and Siegelbaum S.A. Hyperpolarization-activated cation currents: from molecules to physiological function. Ann Rev Physiol 65 (2003) 453-480
23. Wainger B.J., DeGennaro M., Santoro B., Siegelbaum S.A., and Tibbs G.R. Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature 411 (2001) 805-810
24. Wang J., Chen S., and Siegelbaum S.A. Regulation of hyperpolarization-activated HCN channel gating and cAMP modulation due to interactions of COOH terminus and core transmembrane regions. J Gen Physiol 118 3 (2001) 237-250
25. Kaupp U.B., and Seifert R. Molecular diversity of pacemaker ion channels. Annu Rev Physiol 63 (2001) 235-257
26. Decher N., Chen J., and Sanguinetti M.C. Voltage-dependent gating of hyperpolarization-activated, cyclic nucleotide-gated pacemaker channels: molecular coupling between the S4-S5 and C-linkers. J Biol Chem 279 14 (2004) 13859-13865
27. f in canine Purkinje fibers and myocytes. Pflug Arch 422 (1993) 614-616
28. f) by cAMP gating and phosphatase inhibition in rabbit sino-atrial node myocytes. J Physiol (Lond) 500 (1997) 643-651
29. Yu H.G., Lu Z., Pan Z., and Cohen I.S. Tyrosine kinase inhibition differentially regulates heterologously expressed HCN channels. Pflug Arch 447 4 (2004) 392-400
30. Zong X., Eckert C., Yuan H., Wahl-Schott C., Abicht H., Fang L., et al. A novel mechanism of modulation of hyperpolarization-activated cyclic nucleotide-gated channels by SRC kinase. J Biol Chem 280 40 (2005) 34224-34232
31. Rosen M.R., Brink P.R., Cohen I.S., and Robinson R.B. Adult human stem cells as a platform for gene therapy: fabricating a biological pacemaker. Discov Med 5 (2005) 18-24
32. Cohen I.S., Brink P.R., Robinson R.B., and Rosen M.R. The why, what, how and when of biological pacemakers. Nat Clin Pract Cardiovasc Med 2 (2005) 374-375
33. Mocini D., Colivicchi F., and Santini M. Stem cell therapy for cardiac arrhythmias. Ital Heart J 6 3 (2005) 267-271
34. Donahue J.K. Gene therapy for cardiac arrhythmias. Ann NY Acad Sci 1015 (2004) 332-337
35. Gepstein L., and Kehat I. Restoration of heart functions using human embryonic stem cells derived heart muscle cells. Discov Med 5 (2005) 11-17
36. Miake J., Marban E., and Nuss H.B. Functional role of inward rectifier current in heart probed by Kir2.1 over-expression and dominant-negative suppression. J Clin Invest 111 10 (2003) 1529-1536
37. K1-downregulated myocytes. Circ Res 92 (2003) 261-263
38. Shi W., Wymore R., Yu H., Wu J., Wymore R.T., Pan Z., et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res 85 1 (1999) e1-e6
39. Yu H., Wu J., Potapova I., Wymore R.T., Holmes B., Zuckerman J., et al. MinK-related protein 1: A β subunit for the HCN ion channel subunit family enhances expression and speeds activation. Circ Res 88 (2001) e84-e87
40. Qu J., Kryukova Y., Potapova I.A., Doronin S.V., Larsen M., Krishnamurthy G., et al. MiRP1 modulates HCN2 channel expression and gating in cardiac myocytes. J Biol Chem 279 42 (2004) 43497-43502
41. Barbuti A., Gravante B., Riolfo M., Milanesi R., Terragni B., and DiFrancesco D. Localization of pacemaker channels in lipid rafts regulates channel kinetics. Circ Res 94 (2004) 1325-1331
42. Gravante B., Barbuti A., Milanesi R., Zappi I., Viscomi C., and DiFrancesco D. Interaction of the pacemaker channel HCN1 with filamin A. J Biol Chem 279 42 (2004) 43847-43853
43. Santoro B., Wainger B.J., and Siegelbaum S.A. Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. J Neurosci 24 47 (2004) 10750-10762
44. Kimura K., Kitano J., Nakajima Y., and Nakanishi S. Hyperpolarization-activated, cyclic nucleotide-gated HCN2 cation channel forms a protein assembly with multiple neuronal scaffold proteins in distinct modes of protein-protein interaction. Genes Cells 9 7 (2004) 631-640
45. Qu J., Barbuti A., Protas L., Santoro B., Cohen I.S., and Robinson R.B. HCN2 over-expression in newborn and adult ventricular myocytes: distinct effects on gating and excitability. Circ Res 89 (2001) e8-e14
46. Plotnikov AN, Shlapakova IN, Kryukova Y, Bucchi A, Pan Z, Danilo P, Jr., et al. Comparison of mHCN2 and mHCN2-E324A genes as biological pacemakers. Circulation 2005;112:II-126 (abstract).
47. He J.Q., Ma Y., Lee Y., Thomson J.A., and Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93 1 (2003) 32-39
48. Satin J., Kehat I., Caspi O., Huber I., Arbel G., Itzhaki I., et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol (Lond) 559 Pt 2 (2004) 479-496
49. Reppel M., Boettinger C., and Hescheler J. Beta-adrenergic and muscarinic modulation of human embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 14 4-6 (2004) 187-196
50. Stieber J., Herrmann S., Feil S., Loster J., Feil R., Biel M., et al. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc Natl Acad Sci USA 100 25 (2003) 15235-15240
51. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 11 (2000) 1282-1286
52. Valiunas V., Doronin S., Valiuniene L., Potapova I., Zuckerman J., Walcott B., et al. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol (Lond) 555 3 (2004) 617-626
53. Plotnikov AN, Shlapakova IN, Szabolcs MJ, Danilo P, Jr., Lu Z, Potapova I, et al. Adult human mesenchymal stem cells carrying HCN2 gene perform biological pacemaker function with no overt rejection for 6 weeks in canine heart. Circulation 2005;112:II-221 (abstract).
54. Chen J., Mitcheson J.S., Tristani-Firouzi M., Lin M., and Sanguinetti M.C. The S4-S5 linker couples voltage sensing and activation of pacemaker channels. Proc Natl Acad Sci USA 98 20 (2001) 11277-11282
55. Tsang S.Y., Lesso H., and Li R.A. Dissecting the structural and functional roles of the S3-S4 linker of pacemaker (hyperpolarization-activated cyclic nucleotide-modulated) channels by systematic length alterations. J Biol Chem 279 42 (2004) 43752-43759
56. Viscomi C., Altomare C., Bucchi A., Camatini E., Baruscotti M., Moroni A., et al. C terminus-mediated control of voltage and cAMP gating of hyperpolarization-activated cyclic nucleotide-gated channels. J Biol Chem 276 32 (2001) 29930-29934
57. Ishii T.M., Takano M., and Ohmori H. Determinants of activation kinetics in mammalian hyperpolarization-activated cation channels. J Physiol (Lond) 537 1 (2001) 93-100
58. Henrikson C.A., Xue T., Dong P., Sang D., Marban E., and Li R.A. Identification of a surface charged residue in the S3-S4 linker of the pacemaker (HCN) channel that influences activation gating. J Biol Chem 278 16 (2003) 13647-13654